Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study
- PMID: 217290
- DOI: 10.7326/0003-4819-90-1-85
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study
Abstract
Prospective data at Framingham and elsewhere have shown conclusively that risk of coronary heart disease in persons younger than age 50 is strikingly related to the serum total cholesterol level. Within so-called normal limits risk has been found to mount over a five-fold range. The impact has been found to be augmented by other risk factors. The contribution of the serum total cholesterol to risk has also been found to be determined by its partition in the various lipoprotein fractions. A relatively large amount of cholesterol in the low-density lipoprotein fraction is atherogenic, whereas that in the high-density fraction appears protective. The independent contribution of very-low density lipoprotein and its triglyceride or cholesterol content has, on the other hand, not been established. The previous position that virtually all of the lipid information pertaining to coronary heart disease resided in the serum total cholesterol must be accordingly modified.
Similar articles
-
A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study.Am J Med. 1986 Feb 14;80(2A):23-32. doi: 10.1016/0002-9343(86)90157-9. Am J Med. 1986. PMID: 3946458
-
[Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)].Diabete Metab. 1977 Sep;3(3):159-64. Diabete Metab. 1977. PMID: 199484 French.
-
[New approaches to the evaluation of the cholesterol content of plasma lipoprotein fractions in normo- and hyperlipoproteinemias].Kardiologiia. 1978 Jun;18(6):29-36. Kardiologiia. 1978. PMID: 209240 Russian.
-
Relative atherogenicity of different plasma lipoproteins.Adv Exp Med Biol. 1978;109:45-59. doi: 10.1007/978-1-4684-0967-3_3. Adv Exp Med Biol. 1978. PMID: 215009 Review.
-
Serum lipoproteins and coronary heart disease.Am J Cardiol. 1974 Oct 3;34(5):588-93. doi: 10.1016/0002-9149(74)90132-5. Am J Cardiol. 1974. PMID: 4370368 Review. No abstract available.
Cited by
-
Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA.J Lipid Res. 2015 Mar;56(3):703-712. doi: 10.1194/jlr.M055665. Epub 2015 Jan 5. J Lipid Res. 2015. PMID: 25561459 Free PMC article. Clinical Trial.
-
Association of rapid weight gain during early childhood with cardiovascular risk factors in Japanese adolescents.J Epidemiol. 2013;23(2):103-8. doi: 10.2188/jea.je20120107. Epub 2012 Dec 22. J Epidemiol. 2013. PMID: 23269125 Free PMC article.
-
Transcriptional regulation of the apolipoprotein B100 gene: purification and characterization of trans-acting factor BRF-2.Mol Cell Biol. 1992 Jul;12(7):3183-91. doi: 10.1128/mcb.12.7.3183-3191.1992. Mol Cell Biol. 1992. PMID: 1620125 Free PMC article.
-
Ezetimibe in the Treatment of Patients with Metabolic Diseases.Eur Endocrinol. 2013 Mar;9(1):55-60. doi: 10.17925/EE.2013.09.01.55. Epub 2013 Mar 15. Eur Endocrinol. 2013. PMID: 30349611 Free PMC article. Review.
-
Protective effect of dietary capsaicin on induced oxidation of low-density lipoprotein in rats.Mol Cell Biochem. 2005 Jul;275(1-2):7-13. doi: 10.1007/s11010-005-7643-3. Mol Cell Biochem. 2005. PMID: 16335782
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources